• 1
    Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988; 61: 19421956.
  • 2
    Centers for Disease Control. Hepatitis surveillance. Atlanta, GA: Centers for Disease Control, 1990.
  • 3
    Thomas HC, Montano A, Goodal A, de Koning R, Oladapo J, Weidman KH. Immunological mechanisms in chronic hepatitis B infection. Hepatology 1982; 2: S116S121.
  • 4
    Bertoletti A, Ferrari C, Fiaccadori F, Penna A, Margolskee R, Schlicht HJ, Fowler P, et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 1991; 88: 1044510449.
  • 5
    Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, Huang S, et al. Mechanisms of class I restricted immunopathology: a transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 15411554.
  • 6
    Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990; 248: 361364.
  • 7
    Gilles PN, Fey G, Chisari FV. Tumor necrosis factor-alpha negatively regulates hepatitis B virus expression in transgenic mice. J Virol 1992; 66: 39553960.
  • 8
    Guidotti LG, Guilhot S, Chisari FV. Interleukin-2 and alpha/ beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J Virol 1994; 68: 12651270.
  • 9
    Guilhot S, Guidotti LG, Chisari FV. Interleukin-2 down regulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J Virol 1993; 67: 74447449.
  • 10
    Shaul Y, Rutter NJ, Laub O. A human hepatitis B viral enhancer element. EMBO J 1985; 4: 427430.
  • 11
    Yee JK A liver-specific enhancer in the core promoter region of human hepatitis B virus. Science 1989; 246: 658661.
  • 12
    Tur-Kaspa R, Shaul Y, Moore DD, Burk RD, Okret S, Poellinger L, Shafritz DA. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988; 67: 630633.
  • 13
    Schaller H, Fischer M. Transcriptional control of hepadnavirus gene expression. Curr Topics Microbiol Immunol 1991; 168: 2139.
  • 14
    Honigwachs J, Factor O, Dikstein R, Shaul Y, Laub O. Liver-specific expression of the hepatitis B virus is determined by the combined action of the core promoter and the enhancer. J Virol 1989; 63: 919924.
  • 15
    Morrone G, Ciliberto G, Oliviero R, Arcone L, Dente J, Content J, Cortese R. Recombinant interleukin 6 regulates the transcrip-tional activation of a set of human acute phase genes. J Biol Chem 1988; 263: 1255412558.
  • 16
    Gunter U, Arrone C, Toniatti G, Morrone G, Ciliberto G. Dual control of C reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989; 8: 37733779.
  • 17
    Banerjee R, Karpen S, Siekewitz M, Lengyel G, Bauer J, Acs G. Tumor necrosis factor-alpha induces a kappa beta sequence-specific DNA binding protein in human hepatoblastoma HepG2 cells. Hepatology 1989; 10: 10081013.
  • 18
    Edbrooke MR, Burt DW, Chesire JK, Woo P. Identification of cis-acting sequence responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor KB transcription factor. Mol Cell Biol 1989; 9: 19081916.
  • 19
    Ron D, Brasier AR, Wright K, Habener JF. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by interaction between inducible enhancers. Mol Cell Biol 1990; 10: 43894395.
  • 20
    Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Guiberti T, Fiaccadori F, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleo-capsid antigen. J Exp Med 1991; 174: 15651570.
  • 21
    Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, et al. HLA-A31 and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 1993; 177: 751762.
  • 22
    Bertoletti A, Costanzo A, Chisari FV, Levrero M, Artini M, Sette A, Penna A, et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994; 180: 933943.
  • 23
    Sambrooke J, Fritsch EF, Maniatis T. Molecular cloning. Ed 2. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989.
  • 24
    Bruss V, Ganem D. The role of envelope proteins in hepatitis B virus envelope assembly. Proc Natl Acad Sci U S A 1991; 88: 10591063.
  • 25
    Boyum A. Isolation of mononuclear cell and granulocytes from human blood. Scand J Lab Invest 1968; 21: 7789.
  • 26
    Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 1987; 84: 10051009.
  • 27
    Gorman CM, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982; 2: 10441051.
  • 28
    Lavine JE, Hirsch R, Ganem D. A system for studying the selective encapsidation of hepadnavirus RNA. J Virol 1989; 63: 42574263.
  • 29
    Carswell EA, Old LJ, Kassel RL, Green S, Fiorci N, Williamson B. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975; 72: 36663670.
  • 30
    Pesta J, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987; 56: 727777.
  • 31
    Yaginuma K, Koike K. Identification of a promoter region for 3.6 kilobase mRNA of hepatitis B virus and specific cellular binding protein. J Virol 1989; 63: 29142920.
  • 32
    Roossinek MJ, Jameel S, Luokin SH, Siddiqui A. Expression of hepatitis B viral core region in mammalian cells. Mol Cell Biol 1986; 6: 13931400.
  • 33
    Zhang P, Raney A, McLachlan A. Characterization of the hepatitis B virus X- and nucleocapsid gene transcriptional regulatory elements. Virology 1992; 191: 3141.
  • 34
    Zhang P, McLachlan A. Differentiation-specific transcriptional regulation of the hepatitis B virus nucleocapsid gene in human hepatioma cell lines. Virology 1994; 202: 430440.
  • 35
    Nayersina R, Fowler P, Guilhot S, Missale G, Cernay A, Schlicht HJ, Vitiello A, et al. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 1993; 150: 46594671.
  • 36
    Missale G, Brems JJ, Takiff H, Pockros PJ, Chisari FV. Human leukocyte antigen class I-independent pathways may contribute to hepatitis B virus-induced liver disease after liver transplantation. Hepatology 1993; 18: 491496.
  • 37
    Gilles PN, Guerette DL, Ulevitch RJ, Schreiber RD, Chisari FV. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon gamma. Hepatology 1992; 16: 655663.
  • 38
    Milich DR. Immune response to hepatitis B virus proteins: revelance of the murine model. Semin Liver Dis 1991; 11: 93112.
  • 39
    Perlmutter DH, Dinarello CA, Punsal P, Colten HR. Cachectin/ Tumor necrosis factor regulates hepatic acute phase response gene expression. J Clin Invest 1986; 78: 13491354.
  • 40
    Caselmann WH, Meyer M, Scholz S, Hofschneider PH, Koshy R. Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J Infect Dis 1992; 166: 966971.
  • 41
    Zhang Y, Lin JX, Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol 1990; 10: 38183823.
  • 42
    Fujita T, Reis LFL, Watanabe N, Kimura Y, Tangiguchi T, Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci U S A 1989; 86: 99369940.
  • 43
    Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 1988; 54: 903913.
  • 44
    Veals SA, Schindler C, Leonard D, Fu XY, Aebersold R, Darnell JE. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and myb families of DNA-binding proteins. Mol Cell Biol 1992; 12: 33153324.
  • 45
    Faktor O, Shaul Y. The × protein of the hepatitis B virus acts as a transcriptional factor when targeted to its responsive element. EMBO J 1990; 9: 18891895.
  • 46
    Tur-Kaspa R, Teicher L, Laub O, Dagan D, Bloom BR, Schafritz DA. Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription. J Virol 1990; 64: 18211824.
  • 47
    Su H, Yee JK. Regulation of hepatitis B virus gene expression by its two enhancers. Proc Natl Acad Sci U S A 1992; 89: 27082712.
  • 48
    Hamasaki K, Nakata K, Nakao S, Mitsuoka T, Tsutsumi Y, Kato M, Shima N, et al. Interaction of interferon alpha with interleukin 1-beta or tumor necrosis factor alpha on hepatitis B virus enhancer activity. Biochem Biophys Res Commun 1992; 183: 904909.